| Indicators | Browse All

Elutia Inc. (ELUT)

Healthcare | Medical Devices | Gaithersburg, United States | NasdaqCM
0.92 USD -0.06 (-5.670%) ⇩ (July 13, 2026, 4 p.m. EDT)
After hours: 0.92

Short-term:★⯪☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:12 a.m. EDT

The immediate outlook is bearish due to a confluence of deteriorating technicals and severe fundamental distress. Price momentum is clearly negative, with the stock trading significantly below its 50-day average and showing a recent pullback that tests key support levels. This weakness is compounded by a statistically significant downward bias in the short-term forecast model, which predicts further declines over the coming weeks. From a long-term perspective, the investment case is exceptionally weak. The business has suffered a catastrophic multi-year decline, losing nearly 69% of its value over the last four years. While there was a brief recovery in 2024, the most recent annual performance saw a sharp drop of nearly 48%, indicating that the earlier rebound was likely a dead cat bounce rather than a sustainable turnaround. The fundamentals confirm this structural deterioration: the company is burning cash aggressively with operating cash flow and free cash flow both deeply negative, while returning losses to shareholders. The balance sheet is fragile, with debt-to-equity exceeding 18x and negative returns on assets. Although the forward P/E appears low, this is a mathematical artifact of negative earnings, not a sign of undervaluation. With no dividend to provide income and a trajectory of consistent revenue and earnings contraction, the security represents a high-risk speculative bet rather than a viable investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.049265
AutoETS0.050184
MSTL0.050823
AutoARIMA0.083240

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 46%
H-stat 0.92
Ljung-Box p 0.000
Jarque-Bera p 0.097
Excess Kurtosis -0.27
Attribute Value
Sector Healthcare
Debt to Equity Ratio 18.729
Revenue per Share 0.293
Market Cap 40,450,536
Forward P/E -0.83
Beta 0.85
Profit Margins 400.16%
Previous Name Aziyo Biologics, Inc.
Website https://elutia.com

Info Dump

Attribute Value
52 Week Change -0.5302439
Address1 20 Firstfield Road
All Time High 18.2
All Time Low 0.5
Ask 1.2
Ask Size 2
Audit Risk 8
Average Daily Volume10 Day 55,070
Average Daily Volume3 Month 102,568
Average Volume 102,568
Average Volume10Days 55,070
Beta 0.85
Bid 0.6818
Bid Size 2
Board Risk 6
Book Value 0.51
City Gaithersburg
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 9
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.915
Current Ratio 2.048
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 1.0174
Day Low 0.915
Debt To Equity 18.729
Display Name Elutia
Earnings Call Timestamp End 1,778,792,400
Earnings Call Timestamp Start 1,778,792,400
Earnings Timestamp 1,778,788,800
Earnings Timestamp End 1,786,737,600
Earnings Timestamp Start 1,786,737,600
Ebitda -19,271,000
Ebitda Margins -1.54713
Enterprise To Ebitda -0.84
Enterprise To Revenue 1.299
Enterprise Value 16,181,536
Eps Forward -1.1
Eps Trailing Twelve Months -0.65
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 510 307 9896
Fifty Day Average 1.0235
Fifty Day Average Change -0.108499944
Fifty Day Average Change Percent -0.106008746
Fifty Two Week Change Percent -53.024387
Fifty Two Week High 2.5
Fifty Two Week High Change -1.585
Fifty Two Week High Change Percent -0.634
Fifty Two Week Low 0.5
Fifty Two Week Low Change 0.41500002
Fifty Two Week Low Change Percent 0.83000004
Fifty Two Week Range 0.5 - 2.5
Financial Currency USD
First Trade Date Milliseconds 1,602,163,800,000
Float Shares 26,045,724
Forward Eps -1.1
Forward P E -0.83181816
Free Cashflow -27,002,124
Full Exchange Name NasdaqCM
Full Time Employees 25
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.56326
Gross Profits 7,016,000
Has Pre Post Market Data 1
Held Percent Insiders 0.03508
Held Percent Institutions 0.45623
Implied Shares Outstanding 44,208,236
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
Long Name Elutia Inc.
Market us_market
Market Cap 40,450,536
Market State PREPRE
Max Age 86,400
Message Board Id finmb_317199458
Most Recent Quarter 1,774,915,200
Name Change Date 2,026-07-13
Net Income To Common -21,878,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 42,881,988
Number Of Analyst Opinions 1
Open 0.94
Operating Cashflow -43,760,000
Operating Margins -1.84393
Overall Risk 8
Payout Ratio 0.0
Phone 240 247 1170
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 0.915
Post Market Time 1,783,973,404
Prev Name Aziyo Biologics, Inc.
Previous Close 0.97
Price Hint 4
Price To Book 1.7941177
Price To Sales Trailing12 Months 3.247474
Profit Margins 4.0016103
Quick Ratio 1.288
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.055
Regular Market Change Percent -5.6701
Regular Market Day High 1.0174
Regular Market Day Low 0.915
Regular Market Day Range 0.915 - 1.0174
Regular Market Open 0.94
Regular Market Previous Close 0.97
Regular Market Price 0.915
Regular Market Time 1,783,972,801
Regular Market Volume 42,400
Return On Assets -0.26386
Revenue Growth 0.055
Revenue Per Share 0.293
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 44,208,236
Shares Percent Shares Out 0.0011999999
Shares Short 52,925
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 42,627
Short Name Elutia, Inc.
Short Percent Of Float 0.0014
Short Ratio 0.53
Source Interval 15
State MD
Symbol ELUT
Target High Price 5.0
Target Low Price 5.0
Target Mean Price 5.0
Target Median Price 5.0
Total Cash 28,488,000
Total Cash Per Share 0.644
Total Debt 4,219,000
Total Revenue 12,456,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.65
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 0.93998
Two Hundred Day Average Change -0.024979949
Two Hundred Day Average Change Percent -0.02657498
Type Disp Equity
Volume 42,400
Website https://elutia.com
Zip 20,878